A Subgroup Analysis of the FALCON Trial for HR+ Breast Cancer

March 1, 2017
John Robertson, MD

John Robertson, MD, professor of Surgery, University of Nottingham, Royal Derby Hospital Centre, United Kingdom, discusses a subgroup analysis of the FALCON trial, which compared treatment with fulvestrant versus anastrozole in patients with HR-positive advanced breast cancer.